Alteogen Suspends Equity Trading via Free Share Issue

The Korea Exchange announced on July 16 that equity trading in Alteogen (196170), a biologics company, has been suspended. The suspension applies to ordinary shares of Alteogen due to a free share issue. The suspension period is from 3:31 PM on July 16, 2026, until the end of the market session. According to KOSDAQ Market Public Disclosure Regulations and their implementing rules, trading resumption will not be allowed during market hours. If Alteogen has listed futures or options, those will also be suspended. As of Alteogen's December 2025 consolidated financial statements, total assets amount to 698.7 billion won, total liabilities 244.3 billion won, and total equity 454.4 billion won. Revenue reached 215.9 billion won, operating profit 106.9 billion won, and net profit 145.2 billion won. Alteogen, listed on KOSDAQ on December 12, 2014, operates in the field of natural science and engineering R&D. As of 4:10 PM on July 16, 2026, Alteogen's stock price was 276,500 won, down 12,000 won (-4.16%) from the previous day.